AMERICAN SHARED HOSPITAL SERVICES
Datakwaliteit: 100%
AMS
NYSE
Services
Health Services
€ 1,35
▲
€ 0,02
(1,50%)
Marktkapitalisatie: 8,91 M
Prijs
€ 1,35
Marktkapitalisatie
8,91 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 12,35% annually over 5 years — strong growth
Earnings declined -171,04% over the past year
Negative free cash flow of -4,54 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,26%
Groei
Revenue Growth (5Y)
12,35%
Boven sectorgemiddelde (4,21%)
Revenue (1Y)-0,91%
Earnings (1Y)-171,04%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-6,33%
Boven sectorgemiddelde (-15,95%)
ROIC-6,66%
Net Margin-5,53%
Op. Margin-12,78%
Veiligheid
Debt / Equity
0,74
Boven sectorgemiddelde (0,39)
Current Ratio1,20
Interest Coverage-2,28
Waardering
PE (TTM)
-5,74
Onder sectorgemiddelde (-1,17)
P/B Ratio0,36
EV/EBITDA10,35
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,7 | -1,2 |
| P/B | 0,4 | 1,4 |
| ROE % | -6,3 | -16,0 |
| Net Margin % | -5,5 | -18,3 |
| Rev Growth 5Y % | 12,4 | 4,2 |
| D/E | 0,7 | 0,4 |
Koersdoel Analisten
1 analist
Hold
Huidig
€ 1,35
Koersdoel
€ 4,50
€ 4,50
€ 4,50
€ 4,50
Vooruitzicht
Forward K/W
3,38
Forward WPA
€ 0,40
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 | — | 29,73 M | — |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 | — | 7,56 M | — |
| 2026 Q1 | — | 6,87 M | — |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | € 0,02 | -€ 0,09 | -550,0% |
| Q32025 | € 0,00 | € 0,00 | 0,0% |
| Q22025 | -€ 0,07 | -€ 0,04 | +42,9% |
| Q12025 | € 0,04 | -€ 0,10 | -350,0% |
ETFs Holding This Stock
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,91% | Revenue Growth (3Y) | 14,75% |
| Earnings Growth (1Y) | -171,04% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,35% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 28,08 M | Net Income (TTM) | -1,55 M |
| ROE | -6,33% | ROA | -2,52% |
| Gross Margin | 18,03% | Operating Margin | -12,78% |
| Net Margin | -5,53% | Free Cash Flow (TTM) | -4,54 M |
| ROIC | -6,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,74 | Current Ratio | 1,20 |
| Interest Coverage | -2,28 | Asset Turnover | 0,46 |
| Working Capital | 3,42 M | Tangible Book Value | 23,22 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5,74 | Forward P/E | N/A |
| P/B Ratio | 0,36 | P/S Ratio | 0,32 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 10,35 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -50,89% | ||
| Market Cap | 8,91 M | Enterprise Value | 22,00 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,23 | Revenue / Share | 4,25 |
| FCF / Share | -0,69 | OCF / Share | 0,47 |
| EPS CAGR (1Y) | -169,70% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 27,18% | FCF Conversion | 292,08% |
| SBC-Adj. FCF | -4,93 M | Growth Momentum | -13,26 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 28,08 M | 28,34 M | 21,33 M | 19,75 M | 17,63 M |
| Net Income | -1,55 M | 2,19 M | 610.000,0 | 1,33 M | 194.000,0 |
| EPS (Diluted) | -0,23 | 0,33 | 0,10 | 0,21 | 0,03 |
| Gross Profit | 5,06 M | 9,19 M | 9,34 M | 8,38 M | 6,73 M |
| Operating Income | -3,59 M | -2,81 M | 270.000,0 | 2,43 M | 1,35 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 7,08 M | 7,41 M | 7,02 M | 5,15 M | 4,53 M |
| D&A | 5,71 M | 6,17 M | 5,17 M | 4,78 M | 4,97 M |
| Interest Expense | 1,57 M | 1,50 M | 1,11 M | 806.000,0 | 739.000,0 |
| Income Tax | -493.000,0 | -295.000,0 | 431.000,0 | 963.000,0 | 269.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 55,48 M | 60,20 M | 48,16 M | 43,96 M | 45,43 M |
| Total Liabilities | 27,79 M | 30,17 M | 21,88 M | 18,33 M | — |
| Shareholders' Equity | 24,03 M | 25,18 M | 22,62 M | 21,63 M | 19,89 M |
| Total Debt | 17,40 M | 20,41 M | 13,29 M | 13,67 M | 15,70 M |
| Cash & Equivalents | 3,46 M | 11,03 M | 13,69 M | 12,34 M | 8,15 M |
| Current Assets | 17,72 M | 26,26 M | 20,46 M | 18,72 M | 15,09 M |
| Current Liabilities | 23,44 M | 10,41 M | 10,78 M | 5,18 M | 5,89 M |
{"event":"ticker_viewed","properties":{"ticker":"AMS","listing_kind":"stock","pathname":"/stocks/ams","exchange":"NYSE","country":"US"}}
